Core Viewpoint - The company Xinhecheng (002001) experienced a stock price decline of 1.36% to 21.8 yuan as of July 4, 2025, with a trading volume of 317,100 shares and a turnover of 693 million yuan [1]. Group 1: Company Operations - The liquid methionine project in partnership with Sinopec has entered the trial production phase, with mass production dependent on trial outcomes [2]. - The company emphasizes a customer-centric and market-oriented sales strategy, providing innovative and efficient solutions, showcasing its combined "hard power + soft service" capabilities [2]. Group 2: Investor Relations - The company values investor relations management and maintains communication through various channels, including field research, conference calls, and investor hotlines, aiming to convey its value proposition and listen to shareholder feedback [2]. - The company is open to suggestions from investors and is focused on creating long-term value for them [2]. Group 3: Trading Information - On July 4, the net inflow of main funds was 22.21 million yuan, while speculative funds and retail investors saw net outflows of 10.91 million yuan and 11.29 million yuan, respectively [2].

Investment Rating - The report maintains an "Outperform" rating for the company [3][5]. Core Viewpoints - The company has developed into a global leader in fine chemicals, with significant synergy between its vitamin and flavoring industries, leveraging shared intermediates and technical collaboration [1][15]. - Methionine is identified as a key product with strong market potential, and the company is expected to become the third-largest methionine producer globally by 2025, with a production capacity of 550,000 tons per year [2][15]. - The new materials segment focuses on the production of adiponitrile, which is crucial for nylon 66, aiming to address domestic supply issues and reduce costs for downstream applications [2][15]. Summary by Sections Company Overview - The company originated from a school-run factory and has evolved into a comprehensive global fine chemical leader, with five major industries: vitamins, flavoring agents, methionine, polymer materials, and active pharmaceutical ingredients [1][14]. Vitamins and Flavoring Agents - The company is a leading global producer of vitamins, capable of producing eight out of thirteen recognized vitamins, with a strong emphasis on the synergy between its vitamin and flavoring agent businesses [33][34]. Methionine - Methionine is highlighted as a significant product with overlapping customer bases with vitamins, and the company is positioned as a leader in the global methionine market [2][15]. New Materials - The company is strategically focusing on adiponitrile to open long-term growth opportunities, addressing high import dependency and aiming for cost-effective production solutions [2][15]. Financial Forecasts - The projected net profit for the company from 2025 to 2027 is estimated at 6.296 billion, 6.612 billion, and 7.135 billion yuan respectively, with diluted EPS expected to be 2.05, 2.15, and 2.32 yuan [3][4].